| Dr Kyle Richard Carlson, DO | |
|
1824 Dorchester Ct Ste A, Goshen, IN 46526-6819 | |
| (574) 534-2548 | |
| (574) 534-3622 |
| Full Name | Dr Kyle Richard Carlson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 9 Years |
| Location | 1824 Dorchester Ct Ste A, Goshen, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255718367 | NPI | - | NPPES |
| 300052895 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 02006490A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Goshen Hospital | Goshen, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Goshen Health System Inc | 4880598572 | 132 |
News Archive
Michael F. Holick, PhD, MD, director of the General Clinical Research Unit and professor of medicine, physiology and biophysics at Boston University School of Medicine (BUSM) was selected by the American College of Nutrition (ACN) Awards Committee as the 2011 recipient of the ACN Communication Media Award.
Mosquito-borne dengue viruses cause an estimated 50 million cases of human dengue fever a year and are a significant public health threat worldwide. A novel therapeutic approach prevents dengue virus from reproducing in humans by targeting and silencing key regions of the dengue genome essential for viral replication.
University of Arizona doctoral degree candidate Jay Sanguinetti has authored a new study, published online in the journal Psychological Science, that indicates that the brain processes and understands visusal input that we may never consciously perceive.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
› Verified 3 days ago
| Entity Name | Parkview Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
Michael F. Holick, PhD, MD, director of the General Clinical Research Unit and professor of medicine, physiology and biophysics at Boston University School of Medicine (BUSM) was selected by the American College of Nutrition (ACN) Awards Committee as the 2011 recipient of the ACN Communication Media Award.
Mosquito-borne dengue viruses cause an estimated 50 million cases of human dengue fever a year and are a significant public health threat worldwide. A novel therapeutic approach prevents dengue virus from reproducing in humans by targeting and silencing key regions of the dengue genome essential for viral replication.
University of Arizona doctoral degree candidate Jay Sanguinetti has authored a new study, published online in the journal Psychological Science, that indicates that the brain processes and understands visusal input that we may never consciously perceive.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
› Verified 3 days ago
| Entity Name | Goshen Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194772293 PECOS PAC ID: 4880598572 Enrollment ID: O20031124000658 |
News Archive
Michael F. Holick, PhD, MD, director of the General Clinical Research Unit and professor of medicine, physiology and biophysics at Boston University School of Medicine (BUSM) was selected by the American College of Nutrition (ACN) Awards Committee as the 2011 recipient of the ACN Communication Media Award.
Mosquito-borne dengue viruses cause an estimated 50 million cases of human dengue fever a year and are a significant public health threat worldwide. A novel therapeutic approach prevents dengue virus from reproducing in humans by targeting and silencing key regions of the dengue genome essential for viral replication.
University of Arizona doctoral degree candidate Jay Sanguinetti has authored a new study, published online in the journal Psychological Science, that indicates that the brain processes and understands visusal input that we may never consciously perceive.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle Richard Carlson, DO 1824 Dorchester Ct Ste A, Goshen, IN 46526-6819 Ph: (574) 534-2548 | Dr Kyle Richard Carlson, DO 1824 Dorchester Ct Ste A, Goshen, IN 46526-6819 Ph: (574) 534-2548 |
News Archive
Michael F. Holick, PhD, MD, director of the General Clinical Research Unit and professor of medicine, physiology and biophysics at Boston University School of Medicine (BUSM) was selected by the American College of Nutrition (ACN) Awards Committee as the 2011 recipient of the ACN Communication Media Award.
Mosquito-borne dengue viruses cause an estimated 50 million cases of human dengue fever a year and are a significant public health threat worldwide. A novel therapeutic approach prevents dengue virus from reproducing in humans by targeting and silencing key regions of the dengue genome essential for viral replication.
University of Arizona doctoral degree candidate Jay Sanguinetti has authored a new study, published online in the journal Psychological Science, that indicates that the brain processes and understands visusal input that we may never consciously perceive.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.
› Verified 3 days ago
Dr. Karl Thomas Wagner Jr., MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1824 Dorchester Ct, Suite A, Goshen, IN 46526 Phone: 574-534-2548 Fax: 574-534-3622 | |
Dr. Martin L Saltzman, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1824 Dorchester Ct, Goshen, IN 46526 Phone: 574-534-2548 | |
Christopher John Owens, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1824 Dorchester Ct Ste A, Goshen, IN 46526 Phone: 574-534-2548 Fax: 574-534-3622 | |
Dr. Benjamin H Nelson, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 213 Middlebury St, Goshen, IN 46528 Phone: 574-534-3300 Fax: 574-534-5412 | |
Dr. David Chester Koronkiewicz, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1824 Dorchester Ct, Goshen, IN 46526 Phone: 574-534-2548 Fax: 574-534-3622 |